Guardant Health Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.4% | -50.8% | -18.0% | -53.0% | -26.7% | -32.0% | -30.8% | -26.0% | -13.4% | -9.4% | -21.8% | -17.2% | -15.7% | |
| 7.7% | 7.0% | 6.4% | 6.0% | 5.5% | 5.2% | 5.0% | 4.3% | 3.5% | 3.6% | 3.1% | 2.9% | 3.3% | |
| 15.3% | 15.7% | 16.0% | 15.4% | 26.0% | 18.0% | 18.6% | 18.3% | 16.1% | 15.4% | 15.8% | 17.2% | 16.2% | |
| -5.9% | 41.4% | 4.7% | -30.3% | -6.4% | -1.4% | -11.5% | -8.7% | -1.2% | 11.5% | -7.7% | -4.3% | -0.7% | |
| 1.7% | 2.6% | 4.1% | 2.9% | 2.2% | 9.4% | 2.2% | 2.4% | 3.9% | 9.9% | 1.8% | 3.5% | 4.7% | |
| 182.3% | 427.9% | 16.7% | -2.9% | -154.0% | 5.2% | 148.8% | -4.6% | -5.4% | -321.8% | 231.9% | 30.3% | -10.0% | |
| 3.2% | 13.7% | – | – | – | – | – | – | – | – | – | – | – | |
| -2.1% | -2.0% | -0.9% | 4.1% | 0.8% | – | -22.1% | 3.3% | 19.9% | 0.0% | 0.0% | 3.1% | 5.3% | |
| – | – | – | – | – | – | 2.5% | 0.0% | 0.0% | 141.3% | 0.0% | -0.4% | 33.5% | |
| 2.7% | 58.4% | -0.6% | 3.3% | -1.5% | -1.5% | -32.9% | 0.7% | 1.6% | 260.3% | -7.2% | 6.9% | 62.4% | |
| 130.2% | 436.2% | -2.6% | -53.0% | -181.2% | -29.0% | 85.6% | -29.5% | -17.3% | -71.1% | 202.9% | 19.8% | 36.5% | |
| -56.0% | -53.4% | -22.1% | -55.9% | -28.9% | -41.3% | -33.0% | -28.4% | -17.3% | -19.3% | -23.6% | -20.8% | -20.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.